Our knowledge hub brings together the latest EOS Insights from our experts and thought leadership on the pandemic.
14 December 2020
With pharmaceutical companies now rolling out effective vaccines for Covid-19, how do we ensure these are distributed fairly?
With the coronavirus pandemic set to continue without an effective and widely-available vaccine, all eyes are on the pharmaceutical sector.
28 August 2020
A lack of research and development into new antibiotic classes compounds the serious threat that antimicrobial resistance poses to public health.
3 August 2020
The coronavirus has highlighted the importance of being well prepared to respond to emerging global health threats.
2 July 2020
How do deforestation and industrialised agriculture contribute to biodiversity loss, and why should companies ensure sustainable land use throughout their value chains?
As we manage through the coronavirus pandemic, we must not lose sight of the systemic risk posed by the climate crisis.
In this series, we will explore the links between infectious diseases, environmental issues and social sustainability, alongside the role of investors and companies. In part one, Sonya Likhtman looks at how the destruction of ecosystems can increase the risk of pandemics.
Social impacts of the pandemic
In the fifth article in our series about the social impacts of the pandemic, Emily DeMasi looks at how the lack of national paid family and medical leave policies in the US has contributed to widening inequalities.
Many frontline workers lack a voice and have been disproportionately impacted by the pandemic.
The pandemic has highlighted society’s dependency on the gig economy to provide essential services, and the exacerbated risks associated with precarious work.
26 May 2021
The pandemic widened pre-existing racial and ethnic disparities and will continue to exacerbate those inequities unless more is done.
Lisa Lange looks at the disproportionate impact that Covid-19 has had on women, and how this can be addressed.
Other thought leadership
Why companies and investors need to step up to tackle pharmaceutical challenges in a post-pandemic world.
The Covid-19 pandemic is a public health crisis. It is also a major threat to economic sustainability, businesses and individual households.
Government support for companies during the Covid-19 pandemic has demonstrated why all businesses need to maintain a social licence to operate underpinned by a corporate purpose.
The Public Engagement Report highlights some of the stewardship activities undertaken by EOS at Federated Hermes on behalf of its clients over Q2 2020.
9 June 2020
With high street fashion stores closed due to the global pandemic and unsold stock piling up in warehouses, fast fashion is under pressure as never before.